Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pathogen membrane is a lipid bilayer structure that forms the boundary of pathogenic microbial cells such as bacteria, fungi, certain parasites, and enveloped viruses. It is typically composed of phospholipids, proteins, and in some organisms, sterols or glycolipids. The membrane confers structural integrity, regulates transport and signaling, and presents pathogen-associated molecular patterns that are recognized by the immune system. Targeting membrane components is a powerful antimicrobial strategy; however, the term "pathogen membrane" is not a precise molecular identifier and encompasses a complex, diverse set of molecules and functions[1][2][3][4][5][6][7].
Membrane disruption or permeabilization (by antibiotics/antimicrobial peptides); Inhibition of membrane biosynthesis (e.g., via inhibition of lipid synthesis pathways); Targeting specific membrane proteins (e.g., efflux pump inhibitors); Inhibition of envelope fusion (for enveloped viruses)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen membrane.